The global Blood Brain Barrier Technologies Market is entering a period of accelerated growth, expanding from USD 2.74 billion in 2024 to USD 6.8 billion by 2032 at a CAGR of 12.05%. At the heart of this growth lies one of medicine's most persistent challenges: delivering therapeutic agents across the blood-brain barrier (BBB) to treat conditions affecting the central nervous system. With the...